Universal Health Services: The Blue Wave Makes These Shares Very Appealing (Strong Buy)

Impact · against what's priced in

UHS is positioned for a potential valuation re-rating as Democratic control reduces the risk of cuts to its $1.58 billion supplemental Medicaid revenue stream. While legislative cuts from the One Big Beautiful Bill Act are pending for late 2027, the market is currently discounting the stock at 8x earnings, well below its historical 10-12x range.

UHS+0.60

No priced-in read yet